Production of muscular dystrophy mice by molecular engineering
Production of muscular dystrophy mice by molecular engineering
批准号:
09470156
负责人:
SHIMIZU Teruo
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Caveolin-3 is the muscle-specific isoform of the caveolin protein family, which is a major component of caveolae, small membrane invaginations found in most cell types. Caveolins play important roles in the formation of caveola membranes, acting as scaffolding proteins to organize and concentrate lipid-modified signaling molecules, and modulate a signaling pathway. For instance, caveolin-3 interacts with neuronal nitric-oxide synthase (nNOS) and inhibits its catalytic activity. Via the syntrophin-nNOS linkage, caveolin-3 also interacts with the dystroglycan complex, which is a major player of muscle cell adhesion to laminin. Recently, specific mutations in the caveolin-3 gene, including the Pro104Leu missense mutation, have been shown to cause an autosomal dominant limb-girdle muscular dystrophy (LGMD1C), which is characterized by the deficiency of caveolin-3 in the sarcolemma. However, the molecular mechanism by which these mutations cause the deficiency of caveolin-3 and muscle cell degeneration remains elusive. Here we generated transgenic mice expressing the Pro104Leu mutant caveolin-3. They showed severe myopathy accompanied by the deficiency of caveolin-3 in the sarcolemma, indicating a dominant negative effect of mutant caveolin-3. Interestingly, we found a great increase of nNOS activity in their skeletal muscle, which, we propose, may play a role in muscle fiber degeneration in caveolin-3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Chiba, A., Matsumura, K., Yamada, H., Inazu, T., Shimizu, T., Kusunoki, S., Kanazawa, I., Kobata, A., and Endo, T.: "Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve a-dystroglycan: the role of a novel mannosyl type oligosacch
Chiba, A.、Matsumura, K.、Yamada, H.、Inazu, T.、Shimizu, T.、Kusunoki, S.、Kanazawa, I.、Kobata, A. 和 Endo, T.:“唾液酸化的结构
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsumura, K., Chiba, A., Yamada, H., Fukuta-Ohi, H., Fujita, S., Endo, T., Kobata, A., Anderson, L.V.B., Kanazawa, I., Campbell, K.P., and Shimizu, T.: "A role of dystroglycan in schwanomma cell adhesion to laminin."J.Biol.Chem.. 272. 13904-13910 (1997)
松村,K.,千叶,A.,山田,H.,福田大井,H.,藤田,S.,远藤,T.,小畑,A.,安德森,L.V.B.,金泽,I.,坎贝尔,K.P.,
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsumura K et al.: "Sarcoglycan complex : a muscular supporter of dystroglycan-dystrophin interplay?"Cellular and Molecular Biology. 45. 751-762 (1999)
Matsumura K 等人:“肌聚糖复合物:肌营养不良聚糖-肌营养不良蛋白相互作用的肌肉支持者?”细胞和分子生物学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Chiba A et al: "Structure of sialylated O-linked oligosaccharides of peripheral nerve a-dystroglycan: the role of a novel mannosyl type oligosaccharide in the binding with laminin"Journal of Biological Chemistry. 272. 2156-2162 (1997)
Chiba A等人:“周围神经a-肌营养不良聚糖的唾液酸化O-连接寡糖的结构:新型甘露糖基型寡糖在与层粘连蛋白结合中的作用”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsumura, K., Yamada, H., Saito, F., Sunada Y., and Shimizu, T.: "Peripheral nerve inovolvement in merosin-deficient congenital muscular dystrophy and dy mice"Neuromusc. Disord.. 7. 7-12 (1997)
Matsumura, K.、Yamada, H.、Saito, F.、Sunada Y. 和 Shimizu, T.:“merosin 缺陷型先天性肌营养不良症和 dy 小鼠的周围神经参与”Neuromusc。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Development of novel cancer therapy by functional up-regulation of dystroglycan using glycosyltransferase LARGE
-
批准号:24501357
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:SHIMIZU Teruo
-
依托单位:
Molecular pathogenesis of congenital muscular dystrophies and development of new therapeutic measures
-
批准号:16390256
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.76万
-
财政年份:2004
-
负责人:SHIMIZU Teruo
-
依托单位:
Musecle cell dysfunction caused by disturbed cell adhesion and signal transduction
-
批准号:12470143
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2000
-
负责人:SHIMIZU Teruo
-
依托单位:
Characterization of membrane protein complex associated with dystrophin
-
批准号:06454280
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1994
-
负责人:SHIMIZU Teruo
-
依托单位:
Immunochemical analysis of DMD gene product dystrophin
-
批准号:01480238
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1989
-
负责人:SHIMIZU Teruo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
circAbl1/miR-22-3p调控caveolin-3调节心肌细胞焦亡在脓毒症心肌损伤中的作用
-
批准号:2020JJ4777
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:肖锋
-
依托单位:
CircAbl1通过miR-22-3p依赖和非依赖通路调控caveolin-3调节心肌细胞焦亡在脓毒症心肌损伤中的作用及机制研究
-
批准号:81971819
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:肖锋
-
依托单位:
心脏干细胞源μ阿片受体经Caveolin-3/MG53通路介导吗啡预处理减轻慢性心衰心肌缺血后损伤的作用及机制
-
批准号:81801938
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2018
-
负责人:金世云
-
依托单位:
NTs通过NTSR1/Caveolin-3上调HCN通道活性在膀胱过度活动症中的作用机制研究
-
批准号:81700668
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2017
-
负责人:董兴有
-
依托单位:
Caveolin-3通过下调VDAC1/IP3R1维持内质网应激-MAM-线粒体自噬稳态抗糖尿病心肌缺血再灌注损伤
-
批准号:81772049
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:雷少青
-
依托单位:
BDNF减轻糖尿病心肌缺血再灌注损伤的新机制:Caveolin-3/Trk介导的抗细胞程序性坏死
-
批准号:81600251
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:肖锋
-
依托单位:
FAT10稳定Caveolin-3在缺血性心脏病中的作用及机制研究
-
批准号:81600243
-
项目类别:青年科学基金项目
-
资助金额:17.5万元
-
批准年份:2016
-
负责人:熊琴梅
-
依托单位:
PKCε/Caveolin-3对自噬与necroptosis的调控决定糖尿病心肌对缺血后处理的敏感性
-
批准号:81670770
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:夏正远
-
依托单位:
CAV3肌病筛查及临床诊治的基础研究
-
批准号:81660360
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2016
-
负责人:黄勤
-
依托单位:
心梗后心衰患者小窝蛋白Caveolin-3对SCD的预测价值及其机制研究
-
批准号:81470466
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2014
-
负责人:张澍
-
依托单位: